Linked Life Data

21810649

Source:http://linkedlifedata.com/resource/pubmed/id/21810649

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2011-8-3
pubmed:databankReference
pubmed:abstractText
Agitation and psychosis are common in Alzheimer disease and cause considerable morbidity. We attempted to delay or to prevent agitation and psychosis with the use of divalproex sodium (valproate).
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1538-3636
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
68
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
853-61
pubmed:meshHeading
pubmed:year
2011
pubmed:articleTitle
Chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease.
pubmed:affiliation
Banner Alzheimer's Institute, 901 E Willetta St., Phoenix, AZ 85006, USA. pierre.tariot@bannerhealth.com
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Research Support, N.I.H., Extramural